#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14618	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2108	688.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	869	C	816	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25844	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	733.4	0	.	n	.	0	T695C	SNP	695	695	T	961	961	C	752	C	707	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25844	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	733.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2237	2237	C	868	C,T	812,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25844	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	733.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2863	2863	T	753	T,C	618,97	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25844	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	733.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2311	2311	A	830	A	795	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2092	folP	855	855	100.0	folP.l15.c4.ctg.1	1481	140.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1015	1017	AGC	227;227;227	A;G;C	217;216;215	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6040	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3440	175.0	1	SNP	p	S91F	1	.	.	271	273	TTC	623	625	TTC	200;201;203	T;T;C	188;189;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6040	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3440	175.0	1	SNP	p	G95N	0	.	.	283	285	GGC	635	637	GGC	195;193;189	G;G;C	184;180;176	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6040	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3440	175.0	1	SNP	p	D95G	1	.	.	283	285	GGC	635	637	GGC	195;193;189	G;G;C	184;180;176	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1722	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1408	121.9	1	SNP	p	G45D	0	.	.	133	135	GGC	482	484	GGC	194;194;191	G;G;C	181;181;177	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	808	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	943	84.9	0	.	n	.	0	A197.	DEL	197	197	A	527	527	A	185	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	187.9	1	SNP	p	D86N	0	.	.	256	258	GAC	652	654	GAC	222;224;226	G;A;C	207;206;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	187.9	1	SNP	p	R87I	0	.	.	259	261	CGT	655	657	CGT	230;229;223	C;G;T	216;214;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	187.9	1	SNP	p	S87R	1	.	.	259	261	CGT	655	657	CGT	230;229;223	C;G;T	216;214;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	187.9	1	SNP	p	R87W	0	.	.	259	261	CGT	655	657	CGT	230;229;223	C;G;T	216;214;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	187.9	1	SNP	p	S88P	0	.	.	262	264	TCC	658	660	TCC	222;220;219	T;C;C	206;205;205	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4276	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2665	159.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	186;185;185	G;G;C	179;178;177	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1290	1292	GCC	227;229;233	G;C;C	213;215;219	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1293	1295	ATG	231;231;231	A;T;G	218;218;215	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1305	1307	ACC	225;224;224	A;C,T;C	203;201,1;206	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1305	1307	ACC	225;224;224	A;C,T;C	203;201,1;206	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1806	1808	ACC	201;201;198	A;C;C	177;180;181	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1860	1862	GCG	194;193;194	G;C;G	183;181;181	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1860	1862	GCG	194;193;194	G;C;G	183;181;181	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1983	1985	GGT	177;174;175	G;G;T	167;166;166	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1992	1994	AGC	165;166;165	A;G;C	158;160;158	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3884	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	161.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2010	2012	CCG	137;140;138	C,G;C,G;G	99,6;101,2;104	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5812	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3122	185.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1626	1628	CCG	205;208;207	C;C;G	183;189;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2522	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1637	152.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	468	468	C	202	C	190	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2772	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1694	163.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	464	466	GTT	223;223;221	G,A;T;T	212,1;214;214	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2772	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1694	163.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	959	961	AGA	217;216;219	A;G;A	208;208;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2772	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1694	163.1	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1085	1087	GAA	215;214;213	G,A;A;A	205,1;204;205	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2772	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1694	163.1	1	SNP	p	G120K	1	.	.	358	360	AAG	689	691	AAG	252;251;249	A,G;A,G;G,C	230,1;231,1;223,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2772	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1694	163.1	1	SNP	p	A121N	1	.	.	361	363	AAC	692	694	AAC	252;250;249	A;A,G;C	234;231,1;228	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2772	porB1b	1038	1038	99.71	porB1b.l6.c17.ctg.1	1694	163.1	1	SNP	p	N121D	0	.	.	361	363	AAC	692	694	AAC	252;250;249	A;A,G;C	234;231,1;228	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10460	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4674	222.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1128	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1099	102.1	1	SNP	p	V57M	1	.	.	169	171	ATG	539	541	ATG	225;227;229	A;T;G	215;216;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
